Special emphasis was laid on this group of aggressive B-cell lymphomas in recognition of its complicated classification due to the concurrence of features of both Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) including cytogenetic aberrations affecting MYC, BCL2 and/or BCL6 [2]. The gene discussed is MYC; the disease is Burkitt lymphoma.